Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy

BACKGROUND: Gender‐affirming hormone therapy (GAHT) is prescribed to produce secondary sex characteristics aligning external anatomy with gender identity to mitigate gender dysphoria. Transgender women are generally treated with oestrogens and anti‐androgens, whereas transgender men are treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Ky, Huggins, Elizabeth, Sheean, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Nutrition across the Lifespan
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790536/
https://www.ncbi.nlm.nih.gov/pubmed/35509260
http://dx.doi.org/10.1111/jhn.13027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790536/
https://www.ncbi.nlm.nih.gov/pubmed/35509260
http://dx.doi.org/10.1111/jhn.13027

Ejemplares similares